Tradestie Institutional Equity Comparison Engine
WVE vs VOR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VOR Overall Edge
VOR Captures Institutional Edge (4โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, WVE trades at N/M Forward P/E with -320.9% operating margin (+73.0% YoY revenue) versus VOR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, WVE sits in BREAKDOWN (62nd %ile IV; Dealer Gamma Walls on Pro) against VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
VOR
WVE N/M vs VOR N/M Fwd P/E
Growth & Margin Winner
VOR
Op Margin -320.9% vs 0.0% ยท YoY +73.0% vs +0.0%
Momentum & Technical Winner
VOR
1Y -56.8% vs +97.5% ยท 52W Pos 0% vs 65%
Options & Structure Winner
VOR
BREAKDOWN (62nd %ile IV) vs CONSOLIDATION (6th %ile IV)
WVE
NASDAQ
Wave Life Sciences Ltd. Ordinary Shares
Pharmaceutical Preparations
$2.89
-7.82% 1D
Market Cap
$621.3M
1M Return
-7.82%
1Y Return
-56.75%
Forward P/E
N/M
Unified AI Score
41.5 / 100
SELL
Tech 21.0
Fund 46.0
Flow 68.0
Mom 60.0
VOR
NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$19.26
-0.82% 1D
Market Cap
$1.2B
1M Return
+6.82%
1Y Return
+97.54%
Forward P/E
N/M
Unified AI Score
57.8 / 100
HOLD
Tech 50.0
Fund 55.0
Flow 66.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
WVE -56.75%
VOR +97.54%
Spread: +154.29 pp (VOR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
WVE TTM Op. Margin: -320.9%
VOR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WVE vs VOR. Trailing 12-month operating profitability (WVE -320.9% vs VOR 0.0%) and valuation multiples (WVE N/M vs VOR N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | WVE | VOR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $621.3M | $1.2B | Larger Scale | VOR |
| Trailing P/E Ratio Valuation | N/M | 0.1x | Lower Multiple | VOR |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +73.0% | +0.0% | Higher Growth | WVE |
| Operating Margin (TTM) Profitability | -320.9% | 0.0% | Higher Margin | VOR |
| Net Profit Margin Profitability | -296.9% | 0.0% | Higher Margin | VOR |
| Return on Equity (ROE) Capital Efficiency | -78.8% | -125.4% | Higher ROE | WVE |
| 52-Week Range Position Momentum | 0% ($3โ$21) | 65% ($6โ$26) | Stronger Trend | VOR |
| Beta / 30D Volatility Risk Regime | 1.94ฮฒ ยท 76% Vol | 1.91ฮฒ ยท 61% Vol | Lower Realized Risk | VOR |
| Unified Institutional Score Composite Signal | 41.5 / 100 (SELL) | 57.8 / 100 (HOLD) | Higher Composite | VOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full WVE vs VOR Buy Guide
WVE
BREAKDOWN
149d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
62nd %ile
IV Regime
Elevated (60thโ80th %ile)
VOR
CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither WVE nor VOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.